SOPHARMA AD - Convening of a General meeting of warrant holders for June 2 2023

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 20 / 2023

Date of issue: 2023-04-21

Short name of the issuer

SOPHARMA AD

Subject

Convening of a General meeting of warrant holders for June 2 2023

Official market - legal basis

art. 56. 1. 2 of Act on Public Offering.

Unofficial market - legal basis

Contents of the report:

The Board of Directors hereby convenes a General Meeting of the holders of warrants of “SOPHARMA” AD with the unique identification code SFAGMW02062023 to be held on 2 June 2023 at 14:00 hours (11:00 UTC) at the Company's headquarters in Sofia city with place of holding: 5 Lachezar Stanchev Str., Ground Floor, Sopharma Business Towers, Sopharma Event Center, and in the absence of a quorum on that date - on 23 June 2023 at the same location, with the same starting time and agenda. The General Meeting of Warrant holders scheduled to be held on June 2, 2023 be held with the following agenda and with the following proposed resolutions by the Board of Directors: Substantive issues: 1. Adoption of a Report on the movement of the price of ordinary shares of "SOPHARMA" AD on the regulated market, organized by the "Bulgarian Stock Exchange" AD, for the last 12 months; Draft decision: The general meeting of warrant holders accepts a Report on the movement of the price of ordinary shares of "SOPHARMA" AD on the regulated market, organized by the "Bulgarian Stock Exchange" AD, for the last 12 months; 2. Adopting a decision to exercise the warrants’ rights. Draft decision: The general meeting of the holders of warrants with ISIN BG9200001212 adopts a decision to exercise the rights to subscribe shares from a future increase in the capital of "SOPHARMA" AD, by issuing 44 925 943 number of ordinary, registered, dematerialized shares, with the right to vote, with a nominal value of BGN 1 each and an issue value of BGN 4.13 per share, provided that the shares from the increase are subscribed solely by the warrant holders; 3. Requesting that the Board of Directors adopts a decision on a conditional capital increase. Draft decision: Requesting that the Board of Directors adopts a decision on a capital increase under the provisions of the Company's Articles of Association, Art. 195 of the Commercial Code and in accordance with art. 113, para. 2, item 2 of the LPOS, in which the warrant holders can exercise their rights under item 2 of the agenda, and under the terms and conditions described in the Prospectus for the public offering of warrants, confirmed with a Decision of the Financial Supervision Commission № 804 – E/04.11.2021.

Annexes

File Description

SFW_GMW_02062023_EN.rar

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD Farmaceutyczny (far)

(short name of the issuer) (sector according to clasification of the WSE in Warsow)

1220 Sofia

(post code) (city)

IlienskoShosse 16

(street) (number)

[phone] [phone]

(phone number) (fax)

(e-mail) (web site)

nd

(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date Name Position / Function Signature

2023-04-21 Ognian Ivanov Donev Executive Director